{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:35:56Z","timestamp":1778819756901,"version":"3.51.4"},"reference-count":17,"publisher":"Jaypee Brothers Medical Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.5005\/jp-journals-10071-23802","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T11:40:29Z","timestamp":1619782829000},"page":"507-511","source":"Crossref","is-referenced-by-count":16,"title":["Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study"],"prefix":"10.5005","volume":"25","author":[{"given":"SM Gowri","family":"Vishalashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pardeep Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. De Jong E, van Oers J, Beishuizen A, Vos P, Vermeijden W, Haas L, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 2016;16:819\u2013827. DOI: 10.1016\/S1473-3099(16)00053-0.","DOI":"10.1016\/S1473-3099(16)00053-0"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302:1059\u20131066. DOI: 10.1001\/jama.2009.1297.","DOI":"10.1001\/jama.2009.1297"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 2015;109:309\u2013318. DOI: 10.1179\/2047773215Y.0000000030.","DOI":"10.1179\/2047773215Y.0000000030"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A, et al. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control 2013;2:31. DOI: 10.1186\/2047-2994-2-31.","DOI":"10.1186\/2047-2994-2-31"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Rhee C, Jones TM, Hamad Y, Pande A, Varon J, O\u2019Brien C, et al. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw Open 2019;2:e187571. DOI: 10.1001\/jamanetworkopen.2018.7571.","DOI":"10.1001\/jamanetworkopen.2018.7571"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Shorr AF, Micek ST, Welch EC, Doherty JA, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med 2011;39:46\u201351. DOI: 10.1097\/CCM.0b013e3181fa41a7.","DOI":"10.1097\/CCM.0b013e3181fa41a7"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Vincent JL, Teixeira L. Sepsis biomarkers. Value and limitations. Am J Resp Crit Care Med 2014;190:1081\u20131082. DOI: 10.1164\/rccm.201410-1895ED.","DOI":"10.1164\/rccm.201410-1895ED"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Nargis W, Ibrahim M, Ahamed BU. Procalcitonin versus C-reactive protein: usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci 2014;4:195\u2013199. DOI: 10.4103\/2229-5151.141356.","DOI":"10.4103\/2229-5151.141356"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. M\u00fcller B, Becker KL, Sch\u00e4chinger H, Rickenbacher PR, Huber PR, Zimmerli W, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28:977-983. DOI: 10.1097\/00003246-200004000-00011.","DOI":"10.1097\/00003246-200004000-00011"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Nobre V, Harbarth S, Graf J, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients. Am J Respir Crit Care Med 2008;177;498\u2013505. DOI: 10.1164\/rccm.200708-1238OC.","DOI":"10.1164\/rccm.200708-1238OC"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Shehabi Y, Sterba M, Garrett PM, Rachakonda KS, Stephens D, Harrigan P, et al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med 2014;190:1102\u20131110. DOI: 10.1164\/rccm.201408-1483OC.","DOI":"10.1164\/rccm.201408-1483OC"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Boudama L, Luyt C, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375:463\u2013474. DOI: 10.1016\/S0140-6736(09)61879-1.","DOI":"10.1016\/S0140-6736(09)61879-1"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. Schuetz P, Birkhahn R, Sherwin R, Jones A, Singer A, Kline J, et al. Serial procalcitonin predicts mortality in severe sepsis patients. Crit Care Med 2017;45:781\u2013789. DOI: 10.1097\/CCM.0000000000002321.","DOI":"10.1097\/CCM.0000000000002321"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 2009;34:1364\u20131375. DOI: 10.1183\/09031936.00053209.","DOI":"10.1183\/09031936.00053209"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"15. Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011;39:2048\u20132058. DOI: 10.1097\/CCM.0b013e31821e8791.","DOI":"10.1097\/CCM.0b013e31821e8791"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, et al. Effect of sodium selenite administration and procalcitonon-guided therapy on mortality in patients with severe sepsis or septic shock A randomized clinical trial. JAMA Intern Med 2016;176:1266\u20131276. DOI: 10.1001\/jamainternmed.2016.2514.","DOI":"10.1001\/jamainternmed.2016.2514"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. Townsend J, Adams V, Galiatsatos, Pearse D, Pantle H, Masterson M, et al. Procalcitonin-guided antibiotic therapy reduces antibiotic use for lower respiratory tract infections in a United States medical center: results of a clinical trial. Open Forum Infect Dis 2018;5:ofy327. DOI: 10.1093\/ofid\/ofy327.","DOI":"10.1093\/ofid\/ofy327"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.5005\/jp-journals-10071-23802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T16:25:01Z","timestamp":1657902301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.5005\/jp-journals-10071-23802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021]]}},"alternative-id":["10.5005\/jp-journals-10071-23802"],"URL":"https:\/\/doi.org\/10.5005\/jp-journals-10071-23802","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}